From: Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients
Clinicopathological features | No. of cases | miR-224 expression | P | |
---|---|---|---|---|
 |  | Low (n, %) | High (n, %) |  |
Age | Â | Â | Â | Â |
<60 | 58 | 34 (58.6%) | 24 (41.4%) | 0.094 |
≥60 | 57 | 24 (42.1%) | 33 (57.9%) |  |
Gender | Â | Â | Â | Â |
Male | 77 | 40 (51.9%) | 37 (48.1%) | 0.695 |
Female | 38 | 18 (47.4%) | 20 (52.6%) | Â |
Smoking status | Â | Â | Â | Â |
Smoking | 68 | 38 (55.9%) | 30 (44.1%) | 0.591 |
No smoking | 47 | 20 (42.6%) | 27 (57.4%) | Â |
Smoking intensity (for smokers) | Â | Â | Â | Â |
<30 pack years | 38 | 17 (44.7%) | 21 (55.3%) | 0.484 |
≥30 pack years | 30 | 17 (56.7%) | 13 (43.3%) |  |
Occupational exposure | Â | Â | Â | Â |
Yes | 32 | 14 (43.8%) | 18 (56.2%) | 0.411 |
No | 83 | 44 (53.0%) | 39 (47.0%) | Â |
Histological type | Â | Â | Â | Â |
Squamous cell carcinoma | 40 | 23 (57.5%) | 17 (42.5%) | Â |
Adenocarcinoma | 61 | 26 (42.6%) | 35 (57.4%) | 0.186 |
Others | 14 | 9 (64.3%) | 5 (35.7%) | Â |
Histological grade | Â | Â | Â | Â |
G1 + G2 | 61 | 27 (44.3%) | 34 (55.7%) | 0.192 |
G3 | 54 | 31 (57.4%) | 23 (42.6%) | Â |
T classification | Â | Â | Â | Â |
T1+2 | 77 | 36 (46.8%) | 41 (53.2%) | 0.323 |
T3 | 38 | 22 (57.9%) | 16 (42.1%) | Â |
N classification | Â | Â | Â | Â |
Positive | 80 | 48 (60.0%) | 32 (40.0%) | 0.002 |
Negative | 35 | 10 (28.6%) | 25 (71.4%) | Â |
TNM stage | Â | Â | Â | Â |
I + II | 69 | 25 (36.2%) | 44 (63.8%) | <0.001 |
III | 46 | 33 (71.7%) | 13 (28.3%) | Â |